Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lifestyle1966 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08437 | 34035711 | Gastroenterol Hepatol (N Y) | Lifestyle Interventions Beyond Diet and Exercise for Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08465 | 32100496 | Zhongguo Zhen Jiu | [Electroacupuncture combined with lifestyle control on obese nonalcoholic fatty liver disease: a randomized controlled trial]. | 2020 | Details |
| A08472 | 32096890 | Intern Med J | Changing prevalence of aetiological factors and comorbidities among Australians hospitalised for cirrhosis. | 2021 | Details |
| A08484 | 32092046 | Eur J Gastroenterol Hepatol | Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients. | 2020 | Details |
| A08515 | 32077615 | Liver Int | New drugs for non-alcoholic steatohepatitis. | 2020 | Details |
| A08516 | 32077613 | Liver Int | A diabetologist's perspective of non-alcoholic steatohepatitis (NASH): Knowledge gaps and future directions. | 2020 | Details |
| A08519 | 32077608 | Liver Int | Natural history of NASH and HCC. | 2020 | Details |
| A08543 | 32066993 | Frontline Gastroenterol | The Development and Implementation of a Commissioned Pathway for the Identification and Stratification of Liver Disease in the Community. | 2019 | Details |
| A08557 | 32061907 | Metabolism | Established and emerging factors affecting the progression of nonalcoholic fatty liver disease. | 2020 | Details |
| A08560 | 32061596 | Gastroenterology | Therapeutic Landscape for NAFLD in 2020. | 2020 | Details |
| A08582 | 32051820 | Can J Gastroenterol Hepatol | Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach. | 2020 | Details |
| A08585 | 32050765 | J Agric Food Chem | Theaflavin TF3 Relieves Hepatocyte Lipid Deposition through Activating an AMPK Signaling Pathway by targeting Plasma Kallikrein. | 2020 | Details |
| A08601 | 32044317 | Gastroenterology | Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity? | 2020 | Details |
| A08611 | 32042452 | Curr Health Sci J | Before and After Treatment Quantitative Assessment of Hepatic Steatosis in a Romanian Population Using Magnetic Resonance Liver Spectroscopy. | 2019 | Details |
| A08620 | 32039399 | JHEP Rep | Lifestyle modification in NAFLD/NASH: Facts and figures. | 2019 | Details |
| A08622 | 32039394 | JHEP Rep | Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results. | 2019 | Details |
| A08644 | 32033766 | Gastroenterol Clin North Am | Why Do Lifestyle Recommendations Fail in Most Patients with Nonalcoholic Fatty Liver Disease? | 2019 | Details |
| A08645 | 32033765 | Gastroenterol Clin North Am | Nutrition and Nonalcoholic Fatty Liver Disease: Current Perspectives. | 2019 | Details |
| A08663 | 32029220 | Mol Metab | Physical exercise and liver "fitness": Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease. | 2019 | Details |
| A08688 | 32020961 | Med J Armed Forces India | The good, the bad, and the ugly facets of insulin resistance. | 2020 | Details |
| A08701 | 32017891 | Am J Med | Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know? | 2020 | Details |
| A08705 | 32017151 | J Food Biochem | Curcuma longa and Trigonella foenum graecum-enriched nutrient mixture from germinated Macrotyloma uniflorum and Vigna radiate ameliorate nonalcoholic fatty liver diseases in rats. | 2020 | Details |
| A08714 | 32013841 | Curr Pharm Des | Lifestyle Changes for the Treatment of Nonalcoholic Fatty Liver Disease - A 2015-19 Update. | 2020 | Details |
| A08717 | 32012320 | Hepatology | Epidemiological Features of NAFLD From 1999 to 2018 in China. | 2020 | Details |
| A08718 | 32012316 | Hepatology | Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08729 | 32008345 | Orv Hetil | [Effects of physical activity in nonalcoholic fatty liver disease]. | 2020 | Details |
| A08753 | 32000639 | Curr Pharm Des | Dysmetabolic Iron Overload in Metabolic Syndrome. | 2020 | Details |
| A08756 | 31999890 | J Diabetes Investig | Correlation between serum proinsulin levels and fatty liver: The Dynamics of Lifestyle and Neighborhood Community on Health Study. | 2020 | Details |
| A08757 | 31999405 | Turk J Med Sci | Efficacy of Hijamat (wet cupping therapy) in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trial | 2020 | Details |
| A08774 | 31988860 | Euroasian J Hepatogastroenterol | Nonalcoholic Fatty Liver Diseases among Recently Diagnosed Patients with Diabetes Mellitus and Risk Factors. | 2022 | Details |
| A08825 | 31975453 | J Gastroenterol Hepatol | Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population. | 2020 | Details |
| A08896 | 31949537 | Open Access Maced J Med Sci | The Lifestyle Characteristics in Non-Alcoholic Fatty Liver Disease in the PERSIAN Guilan Cohort Study. | 2019 | Details |
| A08897 | 31949229 | Sci Rep | Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis. | 2020 | Details |
| A08933 | 31931543 | Z Gastroenterol | [What is the (right) target for non-alcoholic fatty liver disease (NAFLD)?] | 2020 | Details |
| A08936 | 31930920 | J Med Chem | The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease. | 2020 | Details |
| A08982 | 31915709 | J Diabetes Res | Management of Diabetes Mellitus in Patients with Chronic Liver Diseases. | 2019 | Details |
| A08984 | 31915606 | J Clin Transl Hepatol | Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09016 | 31903714 | Liver Int | Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors? | 2020 | Details |
| A09041 | 31892608 | Anticancer Res | Vitamin D in Preclinical Models of Fatty Liver Disease. | 2020 | Details |
| A09047 | 31889754 | J Clin Exp Hepatol | Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09048 | 31889753 | J Clin Exp Hepatol | Childhood and Adolescent Nonalcoholic Fatty Liver Disease: Is It Different from Adults? | 2019 | Details |
| A09055 | 31888132 | Nutrients | Evaluation of Dietary Approaches for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review. | 2019 | Details |
| A09118 | 31867782 | J Gastroenterol Hepatol | When the liver gets stiff, the tough get moving. | 2020 | Details |
| A09127 | 31865317 | Dig Dis | Nonalcoholic Fatty Pancreas Disease: Clinical Consequences. | 2019 | Details |
| A09159 | 31852635 | Lancet Gastroenterol Hepatol | Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. | 2019 | Details |
| A09175 | 31847612 | Expert Opin Investig Drugs | The molecular basis for current targets of NASH therapies. | 2019 | Details |
| A09179 | 31846961 | Lifestyle Genom | One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics. | 2019 | Details |
| A09183 | 31845776 | Am Fam Physician | Cirrhosis: Diagnosis and Management. | 2019 | Details |
| A09193 | 31840865 | Nutr Clin Pract | Evolution of NAFLD and Its Management. | 2019 | Details |
| A09198 | 31838461 | Nutrition | Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features. | 2019 | Details |
| A09231 | 31826372 | Asia Pac J Clin Nutr | Association between serum ferritin and non-alcoholic fatty liver disease among middle-aged and elderly Chinese with normal weight. | 2019 | Details |
| A09239 | 31822739 | Sci Rep | Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling. | 2019 | Details |
| A09249 | 31817648 | Nutrients | High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths. | 2019 | Details |
| A09251 | 31817398 | Nutrients | Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered. | 2019 | Details |
| A09259 | 31814783 | Hepat Med | A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A09273 | 31809303 | J Chin Med Assoc | CircularRNA as novel biomarkers in liver diseases. | 2020 | Details |
| A09277 | 31808444 | Cureus | Lifestyle Intervention Framework for Obese Patients with Non-alcoholic Fatty Liver Disease - a Tool for Health Professionals in Resource Constraint Settings. | 2019 | Details |
| A09282 | 31806905 | Nat Med | Chronic inflammation in the etiology of disease across the life span. | 2019 | Details |
| A09343 | 31783920 | Syst Rev | Diabetes drugs for nonalcoholic fatty liver disease: a systematic review. | 2019 | Details |
| A09359 | 31779112 | Nutrients | Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer? | 2019 | Details |
| A09360 | 31778277 | Pediatr Diabetes | Prevalence of responders for hepatic fat, adiposity and liver enzyme levels in response to a lifestyle intervention in children with overweight/obesity: EFIGRO randomized controlled trial. | 2019 | Details |
| A09392 | 31762620 | Saudi J Biol Sci | Lifestyle interventions for non-alcoholic fatty liver disease. | 2019 | Details |
| A09396 | 31760676 | Intern Med J | Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. | 2020 | Details |
| A09415 | 31757735 | Presse Med | [Pharmacological treatment of NASH]. | 2019 | Details |
| A09433 | 31752351 | Nutrients | Atorvastatin and Vitamin E Accelerates NASH Resolution by Dietary Intervention in a Preclinical Guinea Pig Model. | 2019 | Details |
| A09447 | 31745030 | Indian J Med Microbiol | Gut microbiota and its mysteries. | 2020 | Details |
| A09453 | 31742325 | Clin Sci (Lond) | Processes exacerbating apoptosis in non-alcoholic steatohepatitis. | 2019 | Details |
| A09462 | 31734987 | Zhonghua Gan Zang Bing Za Zhi | [Expert recommendations on standardized diagnosis and treatment for fatty liver disease in China (2019 revised edition)]. | 2019 | Details |
| A09464 | 31734449 | Clin Gastroenterol Hepatol | Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A09532 | 31705834 | Liver Int | Hypothetical treatment of patients with non-alcoholic steatohepatitis: Potential impact on important clinical outcomes. | 2019 | Details |
| A09542 | 31701087 | Nat Metab | Transcriptional Network Analysis Implicates Altered Hepatic Immune Function in NASH development and resolution. | 2019 | Details |
| A09567 | 31692530 | Pediatric Health Med Ther | Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management. | 2019 | Details |
| A09572 | 31691175 | Curr Obes Rep | Metabolic Syndrome in Children and Adolescents: Diagnostic Criteria, Therapeutic Options and Perspectives. | 2019 | Details |
| A09575 | 31689910 | Nutrients | The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. | 2019 | Details |
| A09591 | 31682643 | Frontline Gastroenterol | A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health. | 2019 | Details |
| A09620 | 31672448 | Metabolism | Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box! | 2019 | Details |
| A09627 | 31670060 | Pharmacol Rep | Hepatoprotective potential of 7,8-Dihydroxyflavone against alcohol and high-fat diet induced liver toxicity via attenuation of oxido-nitrosative stress and NF-κB activation. | 2019 | Details |
| A09631 | 31668723 | Clin Nutr | Dietary n-6 to n-3 fatty acid ratio is related to liver fat content independent of genetic effects: Evidence from the monozygotic co-twin control design. | 2019 | Details |
| A09667 | 31652839 | Int J Mol Sci | The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications. | 2019 | Details |
| A09685 | 31649787 | Prz Gastroenterol | Non-alcoholic fatty liver disease in Poland: how and at what stage is diagnosed, and how is treated. A survey study. | 2019 | Details |
| A09694 | 31645151 | Expert Rev Gastroenterol Hepatol | From circadian clocks to non-alcoholic fatty liver disease. | 2019 | Details |
| A09696 | 31643035 | Dig Dis Sci | Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern? | 2019 | Details |
| A09721 | 31634357 | PLoS One | Modeling the natural history of fatty liver using lifestyle-related risk factors: Effects of body mass index (BMI) on the life-course of fatty liver. | 2019 | Details |
| A09738 | 31630897 | Trends Endocrinol Metab | NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin? | 2019 | Details |
| A09779 | 31614491 | Int J Mol Sci | Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products. | 2019 | Details |
| A09804 | 31604107 | Life Sci | Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. | 2019 | Details |
| A09855 | 31590127 | Biomed Pharmacother | Nr2e1 ablation impairs liver glucolipid metabolism and induces inflammation, high-fat diets amplify the damage. | 2019 | Details |
| A09866 | 31584360 | Curr Med Chem | Stem Cell Transplant for Advanced Stage Liver Disorders: Current Scenario and Future Prospects. | 2020 | Details |
| A09907 | 31566148 | Public Health Nutr | Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and elderly adults. | 2019 | Details |
| A09978 | 31538291 | Endocrine | Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. | 2019 | Details |
| A10006 | 31528245 | World J Hepatol | Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice. | 2019 | Details |
| A10033 | 31518646 | J Hepatol | A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe. | 2019 | Details |
| A10043 | 31516266 | J Clin Exp Hepatol | Magnitude of Nonalcoholic Fatty Liver Disease: Western Perspective. | 2019 | Details |
| A10126 | 31474631 | Yakugaku Zasshi | [Inhibition of Group IVA Phospholipase A2 as a Novel Therapeutic Strategy for Nonalcoholic Steatohepatitis]. | 2019 | Details |
| A10127 | 31474630 | Yakugaku Zasshi | [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management]. | 2019 | Details |
| A10139 | 31470786 | Curr Pharm Des | A Mitochondrial Approach to Cardiovascular Risk and Disease. | 2019 | Details |
| A10173 | 31454802 | Lifestyle Genom | Four-Week Omega-3 Supplementation in Carriers of the Prosteatotic PNPLA3 p.I148M Genetic Variant: An Open-Label Study. | 2019 | Details |
| A10179 | 31447675 | Front Pharmacol | NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment. | 2019 | Details |
| A10197 | 31438482 | Int J Environ Res Public Health | Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. | 2019 | Details |
| A10204 | 31434683 | Postgrad Med J | Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials. | 2019 | Details |